BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2652549)

  • 1. Histological changes in renal allografts after successful conversion from cyclosporin A to azathioprine.
    Junor BJ; More IA; Bradley JA; Briggs JD; Kyle KF; McGregor E; McMillan MA; Macpherson SG; Van der Merwe W; Rodger RS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1677-9. PubMed ID: 2652549
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin A treatment with successful selective conversion after six months in 70 renal allograft recipients.
    Venning MC; Lennard TW; Stevens ME; Proud G; Ward MK; Elliott RW; Taylor RM; Wilkinson R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1633-4. PubMed ID: 2652533
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation.
    Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 5. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
    Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
    Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal graft histology in patients treated with different doses of cyclosporine.
    Wilczek HE; Bohman SO; Groth CG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1672-3. PubMed ID: 2652547
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H; Lange H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract]   [Full Text] [Related]  

  • 10. Skin test reactivity and lymphocyte subsets in cyclosporine versus azathioprine-treated renal transplant recipients.
    Pomer S; Daniel V; Dreikorn K; Röhl L
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1568-9. PubMed ID: 3079026
    [No Abstract]   [Full Text] [Related]  

  • 11. Triple combination of low-dose cyclosporine, azathioprine, and steroids in first cadaver donor renal allografts.
    Fries D; Hiesse C; Charpentier B; Rieu P; Neyrat N; Cantarovich M; Ouziala M; Bellamy J; Benoit G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1911-4. PubMed ID: 3547895
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants.
    Santelli G; Hiesse C; Schovaert D; Fassi-Fihri S; Lantz O; Bensadoun H; Benoit G; Charpentier B; Martin E; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1674-6. PubMed ID: 2652548
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 16. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
    Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
    [No Abstract]   [Full Text] [Related]  

  • 17. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring the response to anti-rejection therapy with serum neopterin.
    Smillie AE; Rigby RJ; Petrie JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone repair in cyclosporin treated renal transplant patients.
    Wilmink JM; Bras J; Surachno S; van Heyst JL; van der Horst JM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1492-4. PubMed ID: 2652480
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
    Isoniemi H; Eklund B; Höckerstedt K; Korsbäck C; Salmela K; von Willebrand E; Häyry P; Ahonen J
    Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.